Table 1.

Demographic and Clinical Features of Enrolled Patients

	HM (n = 100)	ST (n = 114)	ID (n = 79)	ND (n = 82)
Sex (no., %)
Male	54 (54.0%)	48 (42.1%)	32 (40.5)	32 (39.0)
Female	46 (46.0%)	66 (57.9%)	47 (59.5)	50 (61.0)
Age (median, IQR)	61 (52–69)	62 (54–70)	58 (48–64)	55 (39–65)
Comorbidities (no., %)a
Yes	63 (63.6%)	66 (62.3%)	44 (55.7%)	38 (46.3%)
Metabolic	17 (17.0%)	20 (17.5%)	14 (17.7%)	4 (4.9%)
Cardiological	35 (35.0%)	42 (36.8%)	12 (15.2%)	21 (25.6%)
Pneumological	5 (5.0%)	5 (4.4%)	17 (21.5%)	9 (11.0%)
Other	39 (39.0%)	39 (34.2%)	28 (35.4%)	24 (29.3%)

Abbreviations: HM, hematological malignancies; ID, immunorheumatological diseases; ND, neurological disorders; ST, solid tumors.

Comorbidities include metabolic, cardiological, pneumological, and other relevant diseases.